SaaS startup Bigfinite raises $15M Series B financing from Atlantic Bridge and Honeywell Ventures to disrupt manufacturing analytics
Bigfinite, a SaaS startup that provides simple solutions to complex needs in biotech and pharma, has closed $15 million in financing to support the market expansion of Bigfinite’s SaaS platform. The round was led by Atlantic Bridge, Honeywell Ventures and Institut Català de Finances, with participation from existing investors including Uncork Capital, Crosslink Capital and La Famiglia. To date, Bigfinite has raised a total of more than $23.5 million.
Founded in 2014 by Pep Gubau and Pere Merino, the San Francisco-based Bigfinite’s AI-powered SaaS platform helps pharmaceutical and biotech companies discover new ways to optimize manufacturing processes, reduce quality issues, and enhance regulatory compliance. The company is based in San Francisco, California and also has a European office in Barcelona, Spain.
By offering a SAAS application for industrial use, under the philosophy of “Internet of Things”, that can be quickly implemented, without having to adapt or change the currently existing systems and with a customer ROI under six months.
Bigfinite is a solutions provider that transforms manufacturing operations with the use of advanced analytics, artificial intelligence, and pharma 4.0 technologies focused on optimizing pharmaceutical and biotech companies. The Bigfinite analytics platform seamlessly integrates unlimited sources of structured and unstructured data to deliver actionable insights across all manufacturing sites. Bigfinite offers an intuitive way to gain meaningful operational intelligence with data by enabling real-time visibility and predictive insights in a GxP compliant manner with end-to-end data integrity.
“Atlantic Bridge has an extraordinary track record of investment into the next wave of computing including in artificial intelligence (AI), big data, and Industry 4.0 while Honeywell Ventures’ expertise in the Internet of Things, analytics, and advanced manufacturing make this an ideal investment partnership for Bigfinite,” said CEO and co-founder, Pep Gubau. “We are honored and look forward to partnering with these organizations to further scale Bigfinite’s footprint within the life science manufacturing industry.”
“It is well known that billions of dollars annually could be saved through manufacturing process improvements and that a tremendous amount of data is never used,” said Andrew Smyth, Investment Director at Atlantic Bridge. “Bigfinite’s practical use of AI to provide predictive models will save the industry millions in lost product and dramatic reduction of effort to ensure compliance and data integrity.”
“Manufacturers around the world, particularly those in highly regulated industries, are looking for new and innovative ways to use data to optimize their operations,” said Murray Grainger, managing director, Honeywell Ventures. “Honeywell is pleased to make a strategic investment in Bigfinite, whose innovative platform will allow for life sciences manufacturing to be conducted in a faster and more productive manner, while enhancing compliance.”